Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lung Neoplasm Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00265200
What this trial is testing

Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell LungMetastases
University of Louisville 28
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)WithdrawnNCT03786419
What this trial is testing

Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma, AdvancedMalignant Pleural Mesothelioma, Unresectable
Health Pharma Professional Research
Not applicableStudy completedNCT02616211
What this trial is testing

An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors

Who this might be right for
Adenocarcinoma of LungLung NeoplasmCancer of Lung+4 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00101283
What this trial is testing

Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Eastern Cooperative Oncology Group 32
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Not applicableLooking for participantsNCT05857995
What this trial is testing

Precision Lung Cancer Survivorship Care Intervention

Who this might be right for
Lung CancerPulmonary NeoplasmNeoplasms, Lung+12 more
Jerod L Stapleton, PhD 300
Large-scale testing (Phase 3)Study completedNCT03134872
What this trial is testing

SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+6 more
Jiangsu HengRui Medicine Co., Ltd. 419
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299
What this trial is testing

Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more
M.D. Anderson Cancer Center 35
Not applicableActive Not RecruitingNCT04761107
What this trial is testing

Impact of COVID-19 on GU Disease

Who this might be right for
COVID-19 InfectionGenitourinary CancerBenign Urologic Conditions
Icahn School of Medicine at Mount Sinai 15,240
Not applicableLooking for participantsNCT07045532
What this trial is testing

Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI

Who this might be right for
COPDLung Cancers
Shanghai Chest Hospital 100
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Early research (Phase 1)Ended earlyNCT05480865
What this trial is testing

SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation

Who this might be right for
Solid Tumor, AdultMetastatic Solid TumorMetastatic NSCLC+1 more
Navire Pharma Inc., a BridgeBio company 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04077099
What this trial is testing

REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Regeneron Pharmaceuticals 95
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01503177
What this trial is testing

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Recurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant Mesothelioma+3 more
Mayo Clinic 15
Not applicableEnded earlyNCT04698681
What this trial is testing

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerNon-Squamous Non-Small Cell Neoplasm of Lung+3 more
Calithera Biosciences, Inc 20
Early research (Phase 1)Study completedNCT00004930
What this trial is testing

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Who this might be right for
Lung CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00126828
What this trial is testing

Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer

Who this might be right for
Carcinoma, Small Cell
AHS Cancer Control Alberta 18
Not applicableUnknownNCT03634826
What this trial is testing

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

Who this might be right for
CarcinomaLung CancerNSCLC+1 more
Peking University People's Hospital 200
Next Page